• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在阿根廷,头孢匹罗与其他第三代头孢菌素针对医院分离菌株的体外活性比较。

In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in Argentina.

作者信息

Casellas J M, Goldberg M, Orellana N, Morosini M I, Negri M C, Arduino S

机构信息

Department of Infectious Diseases and Microbiology, Universidad Católica, Buenos Aires, Argentina.

出版信息

Infection. 1990 May-Jun;18(3):193-5. doi: 10.1007/BF01642115.

DOI:10.1007/BF01642115
PMID:2114372
Abstract

The in vitro activity of cefpirome was evaluated against strains that showed conflicting results for third generation cephalosporins. Against isolates with derepressed inducible chromosomal cephalosporinase (n = 40) cefpirome was the sole cephalosporin with an MIC90 in the susceptible range; Klebsiella spp. with plasmid-mediated beta-lactamases (broad spectrum SHV-2 or SHV-2 type) (n = 40) remained most susceptible to ceftizoxime and cefpirome; against aminoglycoside-resistant Pseudomonas aeruginosa (n = 50), cefpirome was as active as ceftazidime and cefoperazone; against oxacillin-susceptible and oxacillin-resistant Staphylococcus spp., (n = 40), cefpirome was more active than other third generation cephalosporins but killing was inadequate against both oxacillin-resistant staphylococci and enterococci.

摘要

对第三代头孢菌素呈现矛盾结果的菌株进行了头孢匹罗的体外活性评估。对于具有去阻遏诱导型染色体头孢菌素酶的分离株(n = 40),头孢匹罗是唯一MIC90处于敏感范围的头孢菌素;携带质粒介导的β-内酰胺酶(广谱SHV-2或SHV-2型)的克雷伯菌属(n = 40)对头孢唑肟和头孢匹罗仍最敏感;对于耐氨基糖苷类的铜绿假单胞菌(n = 50),头孢匹罗与头孢他啶和头孢哌酮活性相当;对于对苯唑西林敏感和耐药的葡萄球菌属(n = 40),头孢匹罗比其他第三代头孢菌素活性更强,但对耐苯唑西林葡萄球菌和肠球菌的杀菌效果不佳。

相似文献

1
In vitro activity of cefpirome compared with other third generation cephalosporins against nosocomial isolates in Argentina.在阿根廷,头孢匹罗与其他第三代头孢菌素针对医院分离菌株的体外活性比较。
Infection. 1990 May-Jun;18(3):193-5. doi: 10.1007/BF01642115.
2
In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland.头孢匹罗对瑞士血液科、肿瘤科和重症监护病房分离出的微生物的体外活性。
Scand J Infect Dis. 1997;29(6):615-21. doi: 10.3109/00365549709035905.
3
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.头孢匹罗(HR 810)是一种对葡萄球菌、肠杆菌科细菌和铜绿假单胞菌有效的吡啶头孢菌素类药物,其体外活性及对β-内酰胺酶的稳定性。
Infection. 1985 May-Jun;13(3):146-55. doi: 10.1007/BF01642876.
4
In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group.头孢吡肟及其他广谱β-内酰胺类药物对印度尼西亚医疗中心分离细菌的体外评价。印度尼西亚抗菌药物耐药性研究小组。
Diagn Microbiol Infect Dis. 1999 Dec;35(4):285-90. doi: 10.1016/s0732-8893(99)00099-1.
5
In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.新型胃肠外广谱头孢菌素FK037的体外抗菌活性
J Antibiot (Tokyo). 1993 Jan;46(1):71-87. doi: 10.7164/antibiotics.46.71.
6
Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Chemotherapy. 2005 May;51(2-3):80-5. doi: 10.1159/000085614. Epub 2005 May 4.
7
The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres.
J Antimicrob Chemother. 1993 Mar;31(3):345-62. doi: 10.1093/jac/31.3.345.
8
Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.FK037、头孢匹罗、头孢他啶和头孢吡肟对氨基糖苷类敏感及耐药铜绿假单胞菌和假单胞菌属的抗菌活性比较
Chemotherapy. 1994;40(6):391-8. doi: 10.1159/000239298.
9
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):361-4. doi: 10.1016/0732-8893(91)90029-f.
10
In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria.头孢匹罗的体外抗菌活性:一种针对临床重要细菌的新型第四代头孢菌素
J Pak Med Assoc. 2000 Aug;50(8):250-2.

本文引用的文献

1
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.新型广谱氨噻唑基α-甲氧基氨基头孢菌素HR810的体外评价
Antimicrob Agents Chemother. 1984 Jun;25(6):710-8. doi: 10.1128/AAC.25.6.710.
2
The antimicrobial activity of cefpirome, a new cephalosporin.
J Antimicrob Chemother. 1985 Apr;15(4):449-56. doi: 10.1093/jac/15.4.449.
3
Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.头孢匹罗(HR 810)的β-内酰胺酶稳定性,一种具有广谱抗菌活性的新型头孢菌素。
Antimicrob Agents Chemother. 1986 Nov;30(5):713-8. doi: 10.1128/AAC.30.5.713.